Luminex xMAP Technology
Highly-quantitative multiplex analysis of cytokines, chemokines, growth factors, metabolites, etc. in low amount of sample. Luminex’s xMAP® Technology combines advanced fluidics, optics, and digital signal processing with proprietary microsphere technology to deliver multiplexed assay capabilities. Featuring a flexible, open-architecture design, xMAP Technology can be configured to perform a wide variety of protein or nucleic acid assays quickly, cost-effectively, and accurately. Application areas include cancer, immunology, cardiovascular disease, metabolic disease, inflammation, etc.
How does xMAP Technology compare with ELISA and Planar Assays?
Due to robust multiplexing, xMAP Technology potentially delivers more data in less time than other bioassay products, with comparable results to ELISA and microarray. The technology offers several other distinct advantages over traditional methods:
Over 800 research xMAP assays have been developed providing a broad selection of preconfigured and custom assay panels. All assays are performed on the MAGPIX Platform which supports xMAP assays. Below are links to various vendors offering xMAP assays.